Table 1.
Patient’s baseline characteristics
| Variable | Patients (n = 12) |
|---|---|
| Age (years) | 64.1 ± 7.1 |
| Male, n (%) | 7 (58.3) |
| STEMI, n (%) | 3 (25) |
| NSTEMI, UAP, n (%) | 5 (41.7) |
| Stable angina, n (%) | 4 (33.3) |
| Hypertension, n (%) | 9 (75.0) |
| Dyslipidemia, n (%) | 12 (100) |
| Diabetes mellitus, n (%) | 9 (75.0) |
| Insulin users, n (%) | 0 (0) |
| Current smoking, n (%) | 1 (8.3) |
| Past smoking, n (%) | 1 (8.3) |
| LVEF (%) | 64.0 ± 11.4 |
| Serum Cr (μmol/L) | 82.2 ± 17.4 |
| Hemodialysis, n (%) | 0 (0) |
| Aspirin, n (%) | 12 (100) |
| P2Y12 inhibitor, n (%) | 12 (100) |
| Clopidogrel | 11 (91.7) |
| Ticagrelor | 1 (8.3) |
| Statin, n (%) | 12 (100) |
| RAS inhibitor, n (%) | 6 (50.0) |
| β-Blocker, n (%) | 4 (33.3) |
Data are presented as mean ± SD or number (%)
STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, UAP unstable angina pectoris, CAD coronary artery disease, LVEF left ventricular ejection fraction, Cr creatinine, RAS Renin-Angiotensin System